The relevance of the renin-angiotensin system in the development of drugs to combat preeclampsia

22Citations
Citations of this article
43Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Preeclampsia is a hypertensive disorder that occurs during pregnancy. It has an unknown etiology and afects approximately 5-8% of pregnancies worldwide. The pathophysiology of preeclampsia is not yet known, and preeclampsia has been called "a disease of theories." The central symptom of preeclampsia is hypertension. However, the etiology of the hypertension is unknown. In this review, we analyze the molecular mechanisms of preeclampsia with a particular focus on the pathogenesis of the hypertension in preeclampsia and its association with the renin-angiotensin system. In addition, we propose potential alternative strategies to target the renin-angiotensin system, which is enhanced during pregnancy.

Cite

CITATION STYLE

APA

Ueki, N., Takeda, S., Koya, D., & Kanasaki, K. (2015). The relevance of the renin-angiotensin system in the development of drugs to combat preeclampsia. International Journal of Endocrinology. Hindawi Publishing Corporation. https://doi.org/10.1155/2015/572713

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free